*Aloe vera* is a perennial succulent plant belonging to the lily (Liliaceae) family. This plant has been known as the "healing plant" or "silent healer." It has been claimed that Aloe has several important therapeutic properties, including wound healing, thermal injury healing, anti-inflammation immunomodulation, antidiabetic, and hypoglycemic. Using these effects, Aloe is nowadays used in a variety of commercial products, including sun creams, cosmetics, and lotions. However, the whole extracts of Aloe are used, and the relationship between the various components and their effects has not been well elucidated. Therefore, in Aloe research, it is important to isolate single components with biological effects, to examine these effects, and to elucidate their functional mechanism.\[[@ref1][@ref2][@ref3]\]

Wound healing is a complex and highly regulated process that can be compromised by both endogenous factors (pathophysiological) and exo genous factors (micro-organisms). Microbial colonization of both acute and chronic wounds is inevitable, and in most situations, endogenous bacteria predominate, many of which are potentially pathogenic in the wound environment.\[[@ref4]\]

Diabetic foot ulcers (DFUs), a leading cause of amputations, affect 15% of people with diabetes. A series of multiple mechanisms, including decreased cell and growth factor response, lead to diminished peripheral blood flow and decreased local angiogenesis, all of which can contribute to lack of healing in persons with DFUs.\[[@ref5]\]

Against this backdrop, the present study is aimed to determine the wound healing activity of *A. vera* gel ethanolic extract in experimental animal models.

Materials and Methods {#sec1-1}
=====================

Experimental procedure {#sec2-1}
----------------------

### Collection and authentification of A. vera {#sec3-1}

The medicinal plants were identified and collected locally during the month of June, and were authenticated by Botanical Survey of India, Wardha, India. Voucher specimen no. 2008/001 and herbarium sheet were kept in the institute for further references.

### Preparation of A. vera gel and A. vera gel ethanol extract {#sec3-2}

*A. vera* gel was prepared according to method described earlier.\[[@ref6]\] In brief, full-size mature leaves were cut from the plant and the rind removed. The colorless parenchyma was ground in a blender and centrifuged at 10000 rpm for 30 min at 4°C to remove the fibers. The supernatant was lyophilized and stored at room temperature until use. *A. vera* gel was mixed with 95% ethanol and the total volume was made up to 500 ml. After extraction, the volume becomes 385 ml, and after 1 week of drying, 12.6 g powder of *A. vera* gel ethanolic extract is obtained.

Grouping of animals {#sec2-2}
-------------------

Young healthy male Wistar rats weighing 180-225 g were used in the present investigation. Animals were provided with standard pellets and drinking water *ad libitum* and were maintained in 12 h light and dark cycle. The protocol of the experiment was approved (approval no. ACP/01/08-2009) by Institutional Animal Ethics Committee (IAEC), and the experiment was conducted in accordance with the guidelines as per "Guide for the care and use of laboratory animals" and with permission from Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). Male Wistar rats were divided into untreated control (Group I), untreated DFUs (Group II), DFUs treated with *A. vera* gel ethanolic extract (Group III), DFUs treated with topical *A. vera* gel (Group IV), and DFUs treated with *A. vera* gel ethanolic extract and topical *A. vera* gel (Group V) which were daily administered the *A. vera* gel and ethanolic extract for 9 days. Fasting blood glucose levels and percentage of wound ulcer contraction were measured on day 3, 6, and 9.

Phytochemical screening and thin-layer chromatography {#sec2-3}
-----------------------------------------------------

The extract obtained was subjected to various qualitative tests for identification of the constituents present, by using simple and standard qualitative methods described earlier.\[[@ref6][@ref7]\]

Thin-layer chromatography (TLC) was performed to investigate the authenticity of *A. vera* ingredients. Separation was performed on pre-coated 10 × 10 cm high-performance thin layer chromatography (HPTLC) glass plates (sorbent: Silica gel; pore size: 60). Sample and standard volumes of 20 μl were applied to the plates. The plates were developed using a freshly prepared mobile phase of *n*-butanol: *n*-propanol: Glacial acetic acid: Water (30:10:10:10, v/v/v/v). After drying at room temperature, the spots were stained with a solution of anisaldehyde reagent (0.5 ml of anisaldehyde, 10 ml acetic acid, 85 ml methanol, and 5 ml sulfuric acid) by dipping, followed by heating for 5 min at 105-110°C, and comparison was made between test and standard.\[[@ref8]\]

Induction of experimental diabetes {#sec2-4}
----------------------------------

Rats were fasted overnight before being injected with streptozotocin (STZ) at a dose of 60 mg/kg body weight (in 0.1 M citrate buffer, pH 4.5) intraperitoneally (i.p.). Seventy-two hours later, the blood samples were collected and glucose levels were determined to confirm the development of diabetes. Only those animals that showed hyperglycemia (blood glucose level \>200 mg/dl) were used in the experiment.\[[@ref9]\]

Surgical wounding procedures {#sec2-5}
----------------------------

Only those rats with severe diabetes on day 4 (fasting blood glucose \>300 mg/dl) were selected for ulcer induction.\[[@ref10]\] One week after glucose estimation, the ulcer induction was carried out by two methods, i.e. excision and incision wound models. The day of wound induction was considered as day 0. Animals were treated with *A. vera* gel ethanolic extract \[300 mg/kg, per os (p.o.), twice daily\] and *A. vera* gel (30 mg/kg, twice daily) from day 1 to day 9.

Diabetic wound ulcer models {#sec2-6}
---------------------------

### Excision wound ulcer {#sec3-3}

Excision wound ulcer was produced by the method described earlier,\[[@ref10]\] for determination of biochemical parameters and the rate of wound contraction. In brief, on day 0, rats were anesthetized with ketamine \[100 mg/kg, intramuscularly (i.m.)\] and xylazine (5 mg/kg, i.m.) combination. A rectangle was marked on the dorsal surface of the foot using a signet and then a layer of skin in full thickness (standard area 2 × 5 mm) was removed. One day after wound induction (day 1), the wound became slightly larger.

### General parameter (scoring system) {#sec3-4}

The DEPA scoring system includes the depth of the ulcer (D), the extent of bacterial colonization (E), the phase of ulcer healing (P) and the associated underlying etiology (A) was used to evaluate three important parameters of DFUs in addition to the associated underlying cause. Each parameter was rated on a point scale according to the severity and complexity as given in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.\[[@ref11]\]
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### Incision wound ulcer {#sec3-5}

Incision wound ulcer was produced with a slight modification of the earlier described method for excision wound,\[[@ref12]\] for determination of tensile strength. In brief, on day 0, rats were anesthetized with ketamine (100 mg/kg, i.m.) and xylazine (5 mg/kg, i.m.) combination. A rectangle was marked on the dorsal surface of the foot using a signet and then a layer of skin in full thickness (standard area 2 × 5 mm) was removed. One day after wound induction (day 1), the wound became slightly larger, which was parted together by stitching the skin with sutures (non-absorbent) 1 mm apart; continuous threads on both wound edges were tightened for good adaptation of wound.

Measurement of metabolic parameters {#sec2-7}
-----------------------------------

### Blood glucose monitoring {#sec3-6}

Blood samples were collected from the tail vein of overnight fasted rats and the blood glucose levels were estimated using Ascensia Entrust Blood Glucose Meter (Bayer Diagnostics, Dublin Ireland).

### Plasma insulin {#sec3-7}

Fasting plasma insulin was measured using the insulin enzyme-linked immunosorbent assay (ELISA; American Laboratory Products Company, Windham, NH, USA). The regular insulin ELISA was used to analyze plasma from Wistar rats.

Biochemical analyses of excision wounds {#sec2-8}
---------------------------------------

### Estimation of glycosaminoglycans {#sec3-8}

For extraction of total glycosaminoglycans (GAGs) from the granulation tissue, the tissue samples (10-20 mg) were suspended in 1% sodium dodecyl sulfate (SDS) and incubated in a boiling water bath for 10 min. After cooling to room temperature, proteinase K (0.5 mg/ml final concentration) digestion was carried out at 600°C for 18 h. The digested sample was precipitated with an equal volume of 10% tricholoroacetic acid (TCA) and the supernatant was subsequently extracted with cold chloroform: Methanol (2:1 v/v). GAGs were precipitated form the extracted aqueous phase by adding of 4-5 volumes of 95% ethanol saturated with 5% potassium acetate. The precipitate was dissolved in water and the amount of GAGs was determined spectrophotometrically at 224 nm. The results of GAGs estimation were statistically compared and the probability (P) values were calculated.\[[@ref13]\]

### Estimation of DNA {#sec3-9}

For the estimation of DNA, the chopped-off regenerated tissue was homogenized with 10% TCA, followed by serial washing with a mixture of alcohol and sodium acetate, alcohol and ether, and then ether alone. The pellet was suspended in NaOH and left for 20 h at room temperature and centrifuged. Finally, the pellet was resuspended in 10% TCA, and DNA was extracted at 90°C followed by centrifugation. Resultant supernatant was used for DNA estimation.\[[@ref14][@ref15]\]

Determination of wound area {#sec2-9}
---------------------------

On day 1, 3, 6, and 9, the wounds were traced on a transparent paper having a scale in millimeters, and the wound area was measured with a caliper using the method described earlier.\[[@ref16]\] The wound of each animal was photographically documented and expressed in terms of the area calculated and percentage of wound area that had healed. The results of wound contraction studies of all groups were statistically compared and the *P* values were calculated. The wound contraction percentage was determined using the following formula:

Percentage of wound contraction = healed area/total area × 100

Breaking strength {#sec2-10}
-----------------

For measurement of tensile strength, the sutures were removed from the stitched wounds of rats after recovery and the tensile strength was measured as follows. On day 9, the sutures were removed, and on day 10, wound ulcer breaking strength was determined. In brief, on day 10, the newly repaired tissue was excised and one of the edges of the wound was fixed while applying measurable force to the other one. The load (weight) in grams required to disrupt the wound was determined.

Statistical analysis {#sec2-11}
--------------------

The results are expressed as a mean ± Standard Error Mean (SEM). Data were analyzed using one-way analysis of variance (ANOVA) after Newman--Keuls test. *P* \< 0.05 were considered statistically significant in all cases.

Results {#sec1-2}
=======

General parameters {#sec2-12}
------------------

### Phytochemical screening and TLC {#sec3-10}

Phytochemical analysis of the extract showed the presence of C-glycosides, viz. aloe emodin, anthranols, tannins, steroids, saponins, alkaloids, flavanoids, and polyphenol. Results of TLC proved the authentification of sample *A. vera* gel \[[Figure 1](#F1){ref-type="fig"}\].

![TLC of *Aloe vera* product and of authentic sample for comparison](JPBS-6-205-g003){#F1}

Metabolic parameters {#sec2-13}
--------------------

### Fasting blood glucose {#sec3-11}

The administration of single dose of STZ produced significant increase in the blood glucose levels on day 1 and day 9, as compared to vehicle-treated group (*P* \< 0.0001). Administration of *A. vera* ethanolic extract significantly reduced the blood glucose levels in diabetic rats (*P* \< 0.05) on day 9. Topical application of *A. vera* gel did not influence the blood glucose levels in diabetic rats (*P* \> 0.05) \[[Figure 2](#F2){ref-type="fig"}\].

![Fasting blood glucose levels of *Aloe vera* treated and untreated ulcers in diabetic rats. Data are given as mean ± SEM for six animals in each group. Statistically significant results are indicated as \*\*\**P* \< 0.0001](JPBS-6-205-g004){#F2}

### Fasting insulin and calculated insulin resistance {#sec3-12}

Measurement of fasting insulin on day 9 demonstrated relatively low level of insulin in animals with DFUs because increase in blood glucose levels for the excision and incision models with no statistical difference between these groups.

Biochemical analysis of excision wound {#sec2-14}
--------------------------------------

### Determination of GAGs {#sec3-13}

Treated groups had significantly higher level of GAGs as compared to the untreated DFUs. GAGs level was significantly higher in the group treated with *A. vera* ethanolic gel extract when compared to the group administered *A. vera* gel. The increment in GAGs was observed to be higher in diabetic animals treated with both *A. vera* ethanolic extract and topical application of *A. vera* gel (*P* \< 0.0001) compared to that in diabetic rats treated with vehicle \[[Figure 3](#F3){ref-type="fig"}\].

![Glycosaminoglycan content of *Aloe vera* treated and untreated wound ulcers in diabetic rats. Data are given as mean ± SEM for six animals in each group. Statistically significant results are indicated as \*\*\**P* \< 0.0001](JPBS-6-205-g005){#F3}

### Estimation DNA {#sec3-14}

Treated groups had significantly higher level of DNA as compared to untreated DFUs. DNA level was significantly higher in the group treated with *A. vera* gel ethanolic extract when compared to the group treated with *A. vera* gel. The increment in DNA was observed to be higher in diabetic animals treated with both *A. vera* gel ethanolic extract and topical application of *A. vera* gel (*P* \< 0.0001) compared to that in diabetic rats treated with vehicle \[[Figure 4](#F4){ref-type="fig"}\].

![DNA content of *Aloe vera* treated and untreated wound ulcers in diabetic rats. Data are given as mean ± SEM for six animals in each group. Statistically significant results are indicated as \*\*\**P* \< 0.0001](JPBS-6-205-g006){#F4}

Rate of wound contraction and period of epithelialization {#sec2-15}
---------------------------------------------------------

On day 1, all the groups treated with STZ (diabetic groups) exhibited significantly increased wound size compared to control animals (*P* \< 0.05). There was decrease in wound size in the control group (non-diabetic) which showed complete healing on day 9. There was gradual increase in the wound size in vehicle-treated diabetic rats. The wound size was gradually decreased in diabetic animals treated with *A. vera* gel ethanolic extract (*P* \< 0.01) and topical application of *A. vera* gel (*P* \< 0.01) \[[Figure 5](#F5){ref-type="fig"}\].

![Rate of wound ulcer contraction of *Aloe vera* treated and untreated ulcers in diabetic rats. Data are given as mean ± SEM for six animals in each group. Statistically significant results are indicated as \*\*\**P* \< 0.0001](JPBS-6-205-g007){#F5}

Breaking strength (tensile strength) {#sec2-16}
------------------------------------

The treated diabetic group exhibited significantly lower breaking strength compared to vehicle treatment in the non-diabetic group (*P* \< 0.0001). There was increase in breaking strength in the diabetic animals treated with *A. vera* extract (*P* \< 0.0001) and topical application of *A. vera* gel (*P* \< 0.0001) \[[Figure 6](#F6){ref-type="fig"}\].

![Tensile strength of *Aloe vera* treated and untreated wound ulcers in diabetic rats. Data are given as mean ± SEM for six animals in each group. Statistically significant results are indicated as \*\*\**P* \< 0.0001](JPBS-6-205-g008){#F6}

Discussion {#sec1-3}
==========

STZ causes diabetes by rapid depletion of β-cells, which leads to a reduction of insulin release. It is well established that *A. vera* causes hypoglycemia by stimulating the secretion of insulin and insulin synthesis from the existing pancreatic β-cells, and that this compound is active in moderate STZ-induced diabetes, whereas it is inactive in intense STZ diabetes (in which nearly all β-cells have been destroyed). Results show that *A. vera* gel ethanolic extract significantly reduced the blood glucose levels in diabetic rats (*P* \< 0.05) on day 9, compared to other treatments \[[Figure 2](#F2){ref-type="fig"}\]. Treatment of moderate STZ diabetic rats with medicinal plant extract resulted in the activation of β-cells and granulation returning to normal, showing an insulinogenic effect. The antihyperglycemic activity of *A. vera* was associated with an increase in plasma insulin, suggesting that the antihyperglycemic activity of *A. vera* could be due to an insulinogenic activity of the *A. vera* gel ethanolic extract. The increased levels of insulin observed in the present study indicate that the *A. vera* gel ethanolic extract stimulates insulin secretion from the remnant β-cells and from regenerated β-cells.\[[@ref7][@ref12][@ref13]\] Effect of pseudoprototinosaponin AIII and prototinosaponin AIII on glucose uptake and insulin release suggested their hypoglycemic effects are due to their action on hepatic gluconeogenesis or glycogenolysis. Single as well as repeated doses of the bitter principle of *A. vera* showed hypoglycemic effect in diabetic rats, which was through stimulation of synthesis or release of insulin from pancreatic β-cells.\[[@ref16]\]

Processed *A. vera* gel was found to suppress the expression of the adipogenic genes, sterol regulatory element-binding proteins (*SREBP-1a*), fatty acid synthase (*FAS*), and glycerol-3-phosphate acyltransferase (*GPAT*), suggesting that the gel improves insulin resistance by reducing the toxic effects of lipids in the liver.\[[@ref17]\] Based on the findings of another study on STZ-induced diabetic rats, it was suggested that the mechanism of action of *A. vera* extracts in reducing blood glucose levels is by enhancing the glucose metabolism. It was further proposed that the glucose-lowering effect could be explained by an antioxidant mechanism because it attenuated oxidative damage in the brains of STZ-induced mice and reduced peroxidation levels in the kidneys of STZ-induced diabetic rats.\[[@ref18]\]

Diabetes mellitus is known to be associated with a variety of alterations in connective tissue metabolism, as a result of which diabetics face the problem of poor wound healing. Loss of collagen observed in diabetes may be due to decreased levels of synthesis or enhanced catabolism of newly synthesized collagen or both.\[[@ref19]\] As *A. vera* was reported to cause hypoglycemic effects, it was felt that it would be interesting to study its influence on the healing of wounds in diabetic conditions. *A. vera* gel ethanolic extract significantly reduced the wound size in excision wound ulcer model, as well as increased the breaking strength in incision wound ulcer model. Topical application of *A. vera* gel also significantly reduced the wound size and increased the breaking strength \[Figures [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}\]. The reduction in wound size and increase in breaking strength was significantly higher in diabetic rats treated with both oral *A. vera* gel ethanolic extract and topical *A. vera* gel in combination.\[[@ref16][@ref20]\] Results obtained in the present study suggest that treatment of diabetic rats with *A. vera* gel may have a beneficial influence on wound healing.

Collagen is the predominant extracellular protein in the granulation tissue of a healing wound and there is a rapid increase in the synthesis of this protein in the wound area soon after an injury. In addition to providing strength and integrity to the tissue matrix, collagen also plays an important role in hemostasis. Subsequent epithelialization also requires collagen. In the present study, we examined the influence of *A. vera* gel and extract on the collagen content in the granulation tissues of healing full-thickness wounds in diabetic rats. Treatment of wounds with *A. vera* gel ethanolic extract and gel increased the collagen to maximum levels in the granulation tissue, as compared to the untreated diabetic controls \[[Figure 3](#F3){ref-type="fig"}\].

GAGs and proteoglycans are synthesized by fibroblasts in the wound area. These substances form a highly hydrated gel-like ground substance, a provisional matrix on which collagen fibers are embedded. As collagen accumulates, hexosamine levels decrease. Treatment with *A. vera* gel increases the content of ground substance in the granulation tissues. It may be seen that the decrease in hexosamine content was associated with a concomitant increase in collagen content.\[[@ref21]\] Hyaluronic acid, a GAG, is a major component of the extracellular matrix found on cell surface and is the first component of the extracellular matrix to be synthesized during wound healing process.\[[@ref3]\] It is well documented that the levels of GAGs decreased in the diabetic rats as well as in diabetic wound.\[[@ref22]\] Literature reports suggest treatment with hyaluronic acid based products significantly improve healing of DFUs.\[[@ref23]\] Interestingly, oral administration as well as topical application of *A. vera* is reported to increase the hyaluronic acid. Therefore, the reduction in DFUs by *A. vera* could be subsequent to its effect on GAGs \[[Figure 3](#F3){ref-type="fig"}\].\[[@ref3]\]

The protein and DNA content of granulation tissues indicates the level of protein synthesis and cellular proliferation. Higher protein and DNA content (compared to the untreated controls) of the treated wounds suggests that *A. vera*, through an as yet unknown mechanism, stimulates cellular proliferation. The collagen: DNA ratio of the granulation tissues also suggests that *A. vera* gel may increase the synthesis of collagen per cell. The DNA and protein are the major components to be synthesized during wound healing process. It is well documented that DNA and protein levels increase in the diabetic treated rats as well as in diabetic wounds. Interestingly, oral administration as well as topical application of *A. vera* is reported to increase the DNA level \[[Figure 6](#F6){ref-type="fig"}\]. Therefore, the reduction in diabetic foot wound by *A. vera* could be subsequent to its effect on DNA.\[[@ref3]\]

Wound healing is a response to the injured tissue that results in the restoration of tissue integrity. It was shown in several studies that *A. vera* gel could improve wound healing after topical and systemic administration, while others claimed no effect or even a delay in wound healing. Conflicting results obtained may be explained by the stability of the active ingredients, as it was shown that the time of treatment after harvesting was an important factor that determined the activity. Several mechanisms have been proposed for the wound healing effects of *A. vera* gel, which include keeping the wound moist, increasing epithelial cell migration, more rapid maturation of collagen, and reduction in inflammation.\[[@ref24]\] Rodent models of diabetes display impaired wound repair, with decreased wound tensile strength and poor collagen deposition, and have decreased levels of DNA and protein. Moreover, *A. vera* is reported to exhibit anti-inflammatory effect, and increases collagen deposition in wound tissue, tensile strength, DNA content, and protein synthesis.\[[@ref3][@ref25]\] Treatment with *A. vera* has been shown to reduce tissue loss and improve healing in frost bite and electrical injury under non-diabetic conditions.\[[@ref25][@ref26]\] Its beneficial influence on the healing of wounds in both normal and diabetic rats was also observed by Davis *et al*.\[[@ref27][@ref28]\] Certain triterpenes from other plants have been demonstrated to enhance wound healing.\[[@ref29][@ref30]\]

Herbal products that are rich in phenolic compounds, flavonoids, terpenoids, coumarins, glycosides, saponins, bitter principles, and carbohydrates usually show positive effects.\[[@ref31][@ref32][@ref33][@ref34][@ref35][@ref36]\] These compounds were shown to possess potent hypoglycemic, antihyperglycemic, and glucose-suppressive activities. Saponins were confirmed to be bioactive for diabetes and/or diabetic complications by regulating the activity of enzymes related to glucose metabolism and promoting insulin secretion.\[[@ref33]\] Polyphenolic compounds, especially flavonoids, are among the classes of compounds that have received the most attention with regard to their antidiabetic properties.\[[@ref37]\] Flavonoids are natural polyphenolic molecules of plant origin known for their antioxidant, anti-inflammatory, and anticarcinogenic properties.\[[@ref38]\] Dietary intake of flavonoids might prove to be important for alternative diabetes treatments or reducing the risk of the disease. Attempts have been made to determine their potential in improving the function of β-cells of pancreas,\[[@ref33]\] preventing β-cell apoptosis, promoting β-cell proliferation and insulin secretion,\[[@ref38]\] and enhancing insulin activity.\[[@ref39]\] An alcoholic extract of the *A. vera* gel contains compounds such as saponins, naftoquinones, anthroquinones, sterols, and triterpenoids.\[[@ref40]\] These compounds may mediate the beneficial effects of *A. vera*. However, each of these compounds needs to be tested separately to identify the putative active principle of the gel. As reported by Davis *et al*., among the two major constituents of Aloe, glucose-6-phosphate and mannose-6-phosphate, mannose-6-phosphate is the important structural constituent that promotes wound healing and has anti-inflammatory activity.\[[@ref41]\] Glucomannan, a mannose-rich polysaccharide, and gibberellin, a growth hormone, interact with growth factor receptors on the fibroblast, thereby stimulating their activity and proliferation, which in turn significantly increase collagen synthesis after topical and oral administration of *A. vera* gel. *A. vera* gel not only increased collagen content of the wound but also changed collagen composition (more type III) and increased the degree of collagen cross-linking. Due to this, it accelerated wound contraction and increased the breaking strength of resulting scar tissue. An increased synthesis of hyaluronic acid and dermatan sulfate in the granulation tissue of a healing wound following oral or topical treatment has been reported.\[[@ref42]\]

The present study demonstrates that the *A. vera* gel ethanolic extract accelerate wound healing in diabetes. The results suggest that treatment with *A. vera* gel may have a beneficial influence on the various phases of wound healing, i.e. fibroplasia, collagen synthesis and contraction, resulting in faster healing. It is quite possible that the enhanced healing of wounds in diabetic rats by *A. vera* gel is a result of its hypoglycemic activity (since a control over blood glucose levels has been shown to improve wound healing in diabetics) and/or its capacity to stimulate fibroblast function during the healing process. Oral administration of *A. vera* gel ethanolic extract at a dose of 300 mg/kg body weight per day to STZ-induced diabetic rats for a period of 9 days resulted in a significant reduction in fasting blood glucose and a significant improvement in plasma insulin. Topical application of *A. vera* gel at a dose 30 mg/kg body weight per day to STZ-induced diabetic rats for a period of 9 days resulted in no change in blood glucose and plasma insulin levels.

Conclusion {#sec1-4}
==========

On the basis of the results obtained, we conclude that oral administration as well as topical application of *A. vera* gel ethanolic extract significantly reduces blood glucose level and improves the plasma insulin. It also significantly increases the DNA content and the level of GAGs to improve the wound ulcer healing as well as the breaking strength on day 9. Thus, the results of the present study provide a scientific rationale for the use of *A. vera* gel ethanolic extract, and show that the gel attenuated the diabetic foot wound in rats.
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